Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UBS ASSET MANAGEMENT HIGH YIELD CREDIT FUNDDHY · Entity 8862 | Trustee/ · Audit Committee Chairman | December 27, 2016 | December 29, 2016 |
| UBS ASSET MANAGEMENT INCOME FUND, INC.CIK · Entity 8817 | Director · Audit Committee Chairman | December 27, 2016 | December 29, 2016 |
| abrdn Emerging Markets ex-China Fund, Inc.CH · Entity 5686 | Director | November 08, 2017 | November 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UBS ASSET MANAGEMENT HIGH YIELD CREDIT FUND
Report date December 27, 2016 · Filed December 29, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 19,426.61 |
Reported balance
After 2016-12-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-27 · Purchase · Acquired 1,679 · Balance 19,426.61 F1: The total number of shares held following this transaction includes 777.18 shares acquired on 8/22/2016, 9/23/2016, 10/31/2016, 11/30/2016 and 12/29/2016 as part of the fund's dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The total number of shares held following this transaction includes 777.18 shares acquired on 8/22/2016, 9/23/2016, 10/31/2016, 11/30/2016 and 12/29/2016 as part of the fund's dividend reinvestment plan.
UBS ASSET MANAGEMENT INCOME FUND, INC.
Report date December 27, 2016 · Filed December 29, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common stockSEC Table I · non-derivative | Direct | 14,470.2 |
Reported balance
After 2016-12-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-27 · Purchase · Acquired 1,293 · Balance 14,470.2 F1: The total number of shares held following this transaction includes 456.56 shares acquired on 8/19/2016, 9/22/2016, 10/24/2016, 11/22/2016 and 12/21/2016 as part of the fund's dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The total number of shares held following this transaction includes 456.56 shares acquired on 8/19/2016, 9/22/2016, 10/24/2016, 11/22/2016 and 12/21/2016 as part of the fund's dividend reinvestment plan.
abrdn Emerging Markets ex-China Fund, Inc.
Report date November 08, 2017 · Filed November 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,570.54 |
Reported balance
After 2017-11-08 transaction · row 1
1 source rowRow 1 · 2017-11-08 · Purchase · Acquired 449.5027 · Balance 16,570.54 |
Past disclosures · reporting ended (6)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABERDEEN EMERGING MARKETS SMALLER Co OPPORTUNITIES FUND, INC.
Report date April 27, 2018 · Filed May 01, 2018
Section 16 reporting ended · disclosed 2018-05-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Other · Disposed 9,621.7401 · Balance 0 F1: Effective as of April 27, 2018, the Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). Common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $15.6741 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 1.6215. The Reporting Person received 15,601.00 common shares of the Acquiring Fund in exchange for his 9,621.7401 common shares of the Target Fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective as of April 27, 2018, the Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). Common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $15.6741 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 1.6215. The Reporting Person received 15,601.00 common shares of the Acquiring Fund in exchange for his 9,621.7401 common shares of the Target Fund.
ABERDEEN INDONESIA FUND, INC.
Report date April 27, 2018 · Filed May 01, 2018
Section 16 reporting ended · disclosed 2018-05-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Other · Disposed 12,102.1315 · Balance 0 F1: Effective as of April 27, 2018, the Aberdeen Indonesia Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $7.5631 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 0.7824. In the Reorganization, the Reporting Person received 9,468.00 common shares of the Acquiring Fund in exchange for his 12,102.1315 common shares of the Target Fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective as of April 27, 2018, the Aberdeen Indonesia Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $7.5631 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 0.7824. In the Reorganization, the Reporting Person received 9,468.00 common shares of the Acquiring Fund in exchange for his 12,102.1315 common shares of the Target Fund.
ABERDEEN ISRAEL FUND, INC.
Report date April 27, 2018 · Filed May 01, 2018
Section 16 reporting ended · disclosed 2018-05-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Other · Disposed 8,766.4554 · Balance 0 F1: Effective as of April 27, 2018, the Aberdeen Israel Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $19.9425 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.0631. In the Reorganization, the Reporting Person received 18,086.00 common shares of the Acquiring Fund in exchange for his 8,766.4454 common shares of the Target Fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective as of April 27, 2018, the Aberdeen Israel Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $19.9425 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.0631. In the Reorganization, the Reporting Person received 18,086.00 common shares of the Acquiring Fund in exchange for his 8,766.4454 common shares of the Target Fund.
ABERDEEN LATIN AMERICA EQUITY FUND, INC.
Report date April 27, 2018 · Filed May 01, 2018
Section 16 reporting ended · disclosed 2018-05-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-27 transaction · row 1
1 source rowRow 1 · 2018-04-27 · Other · Disposed 7,355.8725 · Balance 0 F1: Effective as of April 27, 2018, the Aberdeen Latin America Equity Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $28.2129 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.9187. In the Reorganization, the Reporting Person received 21,469.00 common shares of the Acquiring Fund in exchange for his 7,355.8725 common shares of the Target Fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective as of April 27, 2018, the Aberdeen Latin America Equity Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $28.2129 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.9187. In the Reorganization, the Reporting Person received 21,469.00 common shares of the Acquiring Fund in exchange for his 7,355.8725 common shares of the Target Fund.
ADAMS DIVERSIFIED EQUITY FUND, INC.
Report date April 21, 2022 · Filed April 26, 2022
Section 16 reporting ended · disclosed 2022-04-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,830.78 |
Reported balance
After 2022-04-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-04-21 · Grant · Acquired 72.26 · Balance 20,830.78 F1: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.77 - $19.61 during 2022. F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 0.438 |
Reported balance
After 2022-04-21 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2022-04-21 · Other · Acquired 0.001 · Balance 0.438 F3: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.77 - $19.61 during 2022. F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 10,575.438 |
Reported balance
After 2022-04-21 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2022-04-21 · Grant · Acquired 1,225 · Balance 10,575.438 F5: Of these shares, 695 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 530 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $18.01. F6: A fractional share in the amount of 0.01 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.54 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account. F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 29,319 |
Reported balance
Holding disclosure · report date 2022-04-21 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 29,319 F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectIndirect/Other | 9,658 |
Reported balance
Holding disclosure · report date 2022-04-21 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 9,658 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.77 - $19.61 during 2022.
F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts.
F3: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.77 - $19.61 during 2022.
F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust.
F5: Of these shares, 695 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 530 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $18.01.
F6: A fractional share in the amount of 0.01 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.54 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account.
ADAMS NATURAL RESOURCES FUND, INC.
Report date April 21, 2022 · Filed April 26, 2022
Section 16 reporting ended · disclosed 2022-04-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,421.72 |
Reported balance
After 2022-04-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-04-21 · Grant · Acquired 43.83 · Balance 7,421.72 F1: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.52 - $22.36 during 2022. F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 43.41 |
Reported balance
After 2022-04-21 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2022-04-21 · Other · Acquired 42.684 · Balance 43.41 F3: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.52 - $22.36 during 2022. F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 4,261.41 |
Reported balance
After 2022-04-21 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2022-04-21 · Grant · Acquired 566 · Balance 4,261.41 F5: Of these shares, 359 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 207 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $21.96. F6: A fractional share in the amount of 0.02 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.26 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account. F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 8,428 |
Reported balance
Holding disclosure · report date 2022-04-21 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 8,428 F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. |
| Common StockSEC Table I · non-derivative | IndirectIndirect/Other | 3,025 |
Reported balance
Holding disclosure · report date 2022-04-21 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 3,025 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.52 - $22.36 during 2022.
F2: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts.
F3: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.52 - $22.36 during 2022.
F4: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust.
F5: Of these shares, 359 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 207 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $21.96.
F6: A fractional share in the amount of 0.02 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.26 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2022 Filed Apr 26, 2022 10:56 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 1,225 | $18.01 | $22,062.25 |
DisclosureSEC source: 0000002230-22-000014 · primary_doc.xml · nonDerivative · entry 3 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 10,575.438 F5 · shares: Of these shares, 695 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 530 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $18.01. F6 · shares: A fractional share in the amount of 0.01 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.54 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account. F2 · balance_after: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. F4 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 10:56 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 0.001 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-22-000014 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0.438 F3 · shares: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.77 - $19.61 during 2022. F4 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 10:56 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 72.26 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-22-000014 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,830.78 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.77 - $19.61 during 2022. F2 · balance_after: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 11:28 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 566 | $21.96 | $12,429.36 |
DisclosureSEC source: 0000216851-22-000017 · primary_doc.xml · nonDerivative · entry 3 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 4,261.41 F5 · shares: Of these shares, 359 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 207 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $21.96. F6 · shares: A fractional share in the amount of 0.02 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.26 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account. F2 · balance_after: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. F4 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 11:28 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 42.684 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-22-000017 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 43.41 F3 · shares: This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.52 - $22.36 during 2022. F4 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| April 21, 2022 Filed Apr 26, 2022 11:28 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 43.83 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-22-000017 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,421.72 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.52 - $22.36 during 2022. F2 · balance_after: Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 11:33 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 2,645.695 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-22-000011 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 19,519.437 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $16.83 - $22.31 during 2021. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 11:33 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 3,471.6 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-22-000011 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,109.07 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.83 - $22.31 during 2021. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 12:47 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 456.537 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-22-000014 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 8,428.726 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $11.30 - $17.69 during 2021. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2021 Filed Feb 9, 2022 12:47 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 467.96 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-22-000014 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,030.17 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $11.30 - $17.69 during 2021. Read SEC document |
| December 31, 2020 Filed Feb 11, 2021 11:14 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 981.262 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-21-000010 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 16,873.742 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $10.17 - $17.63 during 2020. F3 · ownership.nature: By Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2020 Filed Feb 11, 2021 11:14 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 1,288.04 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-21-000010 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,637.47 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $10.17 - $17.63 during 2020. Read SEC document |
| December 31, 2020 Filed Feb 11, 2021 11:55 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 471.872 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-21-000010 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 7,972.189 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $6.11 - $16.70 during 2020. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2020 Filed Feb 11, 2021 11:55 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 483.75 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-21-000010 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,562.21 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $6.11 - $16.70 during 2020. Read SEC document |
| December 31, 2019 Filed Feb 5, 2020 15:35 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 687.788 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-20-000011 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 15,892.48 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $12.37-$16.76 during 2019. F3 · ownership.nature: Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Read SEC document |
| December 31, 2019 Filed Feb 5, 2020 15:35 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 2,712.43 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-20-000011 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,349.43 F1 · shares: Of these shares, 2,339.430 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). An additional 373 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2014 and deferred until 12/31/2019. The Issuer's stock traded in a range of $12.37 - $16.76 during 2019 Read SEC document |
| December 31, 2019 Filed Feb 6, 2020 12:05 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 470.75 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-20-000011 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 7,500.317 F4 · shares: Of these shares, 281.750 were acquired in exempt transactions as a result of dividend reinvestments. An additional 189 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2014 and deferred until 12/31/2019. The Issuer's stock traded in a range of $14.30 - $17.43 during 2019. F2 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2019 Filed Feb 6, 2020 12:05 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 693.23 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-20-000011 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,078.46 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of retainer fees). The Issuer's stock traded in a range of $14.30 - $17.43 during 2019. Read SEC document |
| December 31, 2019 Filed Feb 11, 2020 10:35 UTC Amendment | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 1,060.788 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-20-000012 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 15,892.48 F2 · shares: Of these shares, 687.788 were acquired in exempt transactions as a result of dividend reinvestments. An additional 373 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2014 and deferred until 12/31/2019. The Issuer's stock traded in a range of $12.37-$16.76 during 2019. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2019 Filed Feb 11, 2020 10:35 UTC Amendment | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 2,339.43 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-20-000012 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,349.43 F1 · shares: These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $12.37 - $16.76 during 2019. Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 13:49 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 0.72 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-19-000013 · primary_doc.xml · nonDerivative · entry 3 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,300.632 F4 · shares: This fractional share was issued as part of DSU's (granted in lieu of a 2006 deferred cash retainer) & DE shares earned. The fractional share was surrendered as non-transferrable to a registered account. Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 13:49 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 434.829 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-19-000013 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 57,301.352 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $11.84 - $16.80 during 2018. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 13:49 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | GrantCommon Stock | 4,288.93 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-19-000013 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,866.523 F1 · shares: Of these shares, 3,569.930 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). An additional 719 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2006 and deferred until 12/31/2018. The Issuer's stock traded in a range of $11.84 - $16.80 during 2018. Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 14:17 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 0.92 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-19-000012 · primary_doc.xml · nonDerivative · entry 3 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,440.137 F4 · shares: This fractional share was issued as part of DSU's (granted in lieu of a 2006 deferred cash retainer) & DE shares earned. The fractional share was surrendered as non-transferrable to a registered account. Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 14:17 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 116.558 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-19-000012 · primary_doc.xml · nonDerivative · entry 2 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 19,441.057 F2 · shares: These shares were acquired in exempt transactions as a result of dividend reinvestments. The Issuer's stock traded in a range of $13.61 - $21.48 during 2018. F3 · ownership.nature: By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust. Read SEC document |
| December 31, 2018 Filed Feb 11, 2019 14:17 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | GrantCommon Stock | 1,412.97 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-19-000012 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,324.499 F1 · shares: Of these shares, 707.970 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). An additional 705 shares accrued as dividend equivalents on 400 restricted stock units, which were granted in 2006 and deferred until 12/31/2018. The Issuer's stock traded in a range of $13.61 - $21.48 during 2018. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:46 UTC | ABERDEEN INDONESIA FUND, INC. IF · Entity 167154 | OtherCommon Stock | 12,102.1315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-029402 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Effective as of April 27, 2018, the Aberdeen Indonesia Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $7.5631 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 0.7824. In the Reorganization, the Reporting Person received 9,468.00 common shares of the Acquiring Fund in exchange for his 12,102.1315 common shares of the Target Fund. F1 · price: Effective as of April 27, 2018, the Aberdeen Indonesia Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $7.5631 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 0.7824. In the Reorganization, the Reporting Person received 9,468.00 common shares of the Acquiring Fund in exchange for his 12,102.1315 common shares of the Target Fund. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:31 UTC | ABERDEEN LATIN AMERICA EQUITY FUND, INC. LAQ · Entity 167153 | OtherCommon Stock | 7,355.8725 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-029381 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Effective as of April 27, 2018, the Aberdeen Latin America Equity Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $28.2129 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.9187. In the Reorganization, the Reporting Person received 21,469.00 common shares of the Acquiring Fund in exchange for his 7,355.8725 common shares of the Target Fund. F1 · price: Effective as of April 27, 2018, the Aberdeen Latin America Equity Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $28.2129 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.9187. In the Reorganization, the Reporting Person received 21,469.00 common shares of the Acquiring Fund in exchange for his 7,355.8725 common shares of the Target Fund. Read SEC document |
| April 27, 2018 Filed May 1, 2018 16:47 UTC | ABERDEEN ISRAEL FUND, INC. ISL · Entity 167150 | OtherCommon Stock | 8,766.4554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-029406 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Effective as of April 27, 2018, the Aberdeen Israel Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $19.9425 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.0631. In the Reorganization, the Reporting Person received 18,086.00 common shares of the Acquiring Fund in exchange for his 8,766.4454 common shares of the Target Fund. F1 · price: Effective as of April 27, 2018, the Aberdeen Israel Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $19.9425 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 2.0631. In the Reorganization, the Reporting Person received 18,086.00 common shares of the Acquiring Fund in exchange for his 8,766.4454 common shares of the Target Fund. Read SEC document |
| April 27, 2018 Filed May 1, 2018 15:53 UTC | ABERDEEN EMERGING MARKETS SMALLER Co OPPORTUNITIES FUND, INC. ABE · Entity 167142 | OtherCommon Stock | 9,621.7401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-029335 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Effective as of April 27, 2018, the Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). Common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $15.6741 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 1.6215. The Reporting Person received 15,601.00 common shares of the Acquiring Fund in exchange for his 9,621.7401 common shares of the Target Fund. F1 · price: Effective as of April 27, 2018, the Aberdeen Emerging Markets Smaller Company Opportunities Fund, Inc. (the "Target Fund") was reorganized into the Aberdeen Emerging Markets Equity Income Fund, Inc., formerly, Aberdeen Chile Fund, Inc. (the "Acquiring Fund," and such reorganization, the "Reorganization"). Common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on April 27, 2018, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of April 27, 2018, the Target Fund reported a NAV per share of $15.6741 and the Acquiring Fund reported a NAV per share of $9.6662. The conversion ratio for the Target Fund's common shares was 1.6215. The Reporting Person received 15,601.00 common shares of the Acquiring Fund in exchange for his 9,621.7401 common shares of the Target Fund. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 11:53 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 2,336.156 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-18-000011 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,577.593 F1 · shares: Of these shares, 253.476 were acquired in exempt transactions as a result of dividend reinvestment. An additional 2,082.680 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $17.70 - $20.70 during 2017. Read SEC document |
| December 31, 2017 Filed Jan 25, 2018 12:04 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 696.43 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-18-000011 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,911.529 F1 · shares: Of these shares, 98.412 shares were acquired in exempt transactions as a result of dividend reinvestment. An additional 598.020 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $17.70 - $20.70 during 2017. Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 21:15 UTC | abrdn Emerging Markets ex-China Fund, Inc. CH · Entity 5686 | PurchaseCommon Stock | 449.5027 | $8.87 | $3,986.01 |
DisclosureSEC source: 0001104659-17-067964 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,570.54 Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:14 UTC | ABERDEEN INDONESIA FUND, INC. IF · Entity 167154 | PurchaseCommon Stock | 514.3353 | $7.75 | $3,984.71 |
DisclosureSEC source: 0001104659-17-067959 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,076.98 Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:09 UTC | ABERDEEN LATIN AMERICA EQUITY FUND, INC. LAQ · Entity 167153 | PurchaseCommon Stock | 150.6218 | $26.50 | $3,991.99 |
DisclosureSEC source: 0001104659-17-067946 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,325.17 Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:06 UTC | ABERDEEN ISRAEL FUND, INC. ISL · Entity 167150 | PurchaseCommon Stock | 198.7357 | $20.08 | $3,991.03 |
DisclosureSEC source: 0001104659-17-067940 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,689.4 Read SEC document |
| November 08, 2017 Filed Nov 13, 2017 16:11 UTC | ABERDEEN EMERGING MARKETS SMALLER Co OPPORTUNITIES FUND, INC. ABE · Entity 167142 | PurchaseCommon Stock | 203.0563 | $14.43 | $2,929.94 |
DisclosureSEC source: 0001104659-17-067952 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,604.52 Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 11:21 UTC | abrdn Emerging Markets ex-China Fund, Inc. CH · Entity 5686 | PurchaseCommon Stock | 547.6734 | $7.27 | $3,984.05 |
DisclosureSEC source: 0001104659-17-023500 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,121.04 Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 07:22 UTC | ABERDEEN INDONESIA FUND, INC. IF · Entity 167154 | PurchaseCommon Stock | 544.7895 | $7.31 | $3,984.10 |
DisclosureSEC source: 0001104659-17-023504 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,548.25 Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 07:17 UTC | ABERDEEN LATIN AMERICA EQUITY FUND, INC. LAQ · Entity 167153 | PurchaseCommon Stock | 168.3749 | $23.71 | $3,991.63 |
DisclosureSEC source: 0001104659-17-023488 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,174.55 Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 07:18 UTC | ABERDEEN ISRAEL FUND, INC. ISL · Entity 167150 | PurchaseCommon Stock | 223.8055 | $17.83 | $3,990.52 |
DisclosureSEC source: 0001104659-17-023492 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,449.44 Read SEC document |
| April 12, 2017 Filed Apr 14, 2017 07:20 UTC | ABERDEEN EMERGING MARKETS SMALLER Co OPPORTUNITIES FUND, INC. ABE · Entity 167142 | PurchaseCommon Stock | 295.3022 | $13.51 | $3,989.09 |
DisclosureSEC source: 0001104659-17-023496 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371.89 Read SEC document |
| December 31, 2016 Filed Feb 2, 2017 11:28 UTC | ADAMS DIVERSIFIED EQUITY FUND, INC. ADX · Entity 4182 | OtherCommon Stock | 1,808.33 | $0.00 | $0.00 |
DisclosureSEC source: 0000002230-17-000013 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,241.437 F1 · shares: Of these shares, 196.070 were acquired in exempt transactions as a result of dividend reinvestment. An additional 1,612.260 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $10.96 - $13.25 during 2016. Read SEC document |
| December 31, 2016 Filed Feb 2, 2017 11:44 UTC | ADAMS NATURAL RESOURCES FUND, INC. PEO · Entity 5103 | OtherCommon Stock | 597.634 | $0.00 | $0.00 |
DisclosureSEC source: 0000216851-17-000009 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,215.097 F1 · shares: Of these shares, 84.414 shares were acquired in exempt transactions as a result of dividend reinvestment. An additional 513.220 shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $14.29 - $20.82 during 2016. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 16:43 UTC | UBS ASSET MANAGEMENT INCOME FUND, INC. CIK · Entity 8817 | Purchasecommon stock | 1,293 | $3.48 | $4,499.64 |
DisclosureSEC source: 0001499475-16-000026 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director · Audit Committee Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,470.2 F1 · balance_after: The total number of shares held following this transaction includes 456.56 shares acquired on 8/19/2016, 9/22/2016, 10/24/2016, 11/22/2016 and 12/21/2016 as part of the fund's dividend reinvestment plan. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 11:59 UTC | UBS ASSET MANAGEMENT HIGH YIELD CREDIT FUND DHY · Entity 8862 | Purchasecommon shares | 1,679 | $2.68 | $4,499.72 |
DisclosureSEC source: 0001499475-16-000027 · primary_doc.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Trustee/ · Audit Committee Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,426.61 F1 · balance_after: The total number of shares held following this transaction includes 777.18 shares acquired on 8/22/2016, 9/23/2016, 10/31/2016, 11/30/2016 and 12/29/2016 as part of the fund's dividend reinvestment plan. Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 20:03 UTC | abrdn Emerging Markets ex-China Fund, Inc. CH · Entity 5686 | PurchaseCommon Stock | 620.8037 | $6.42 | $3,982.58 |
DisclosureSEC source: 0001104659-16-156831 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,573.36 Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 15:05 UTC | ABERDEEN INDONESIA FUND, INC. IF · Entity 167154 | PurchaseCommon Stock | 610.7262 | $6.52 | $3,982.79 |
DisclosureSEC source: 0001104659-16-156837 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,003.46 Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 14:58 UTC | ABERDEEN LATIN AMERICA EQUITY FUND, INC. LAQ · Entity 167153 | PurchaseCommon Stock | 183.544 | $21.75 | $3,991.33 |
DisclosureSEC source: 0001104659-16-156813 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,981.24 Read SEC document |
| November 09, 2016 Filed Nov 14, 2016 15:01 UTC | ABERDEEN ISRAEL FUND, INC. ISL · Entity 167150 | PurchaseCommon Stock | 244.7569 | $16.30 | $3,990.10 |
DisclosureSEC source: 0001104659-16-156819 · a4.xml · nonDerivative · entry 1 ARZAC ENRIQUE R · CIK 0001009234 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,142.86 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.